Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth

Journal of Cellular Biochemistry

Volumn 63, Issue 4, 1996, Pages 410-421

  Hatzoglou, Anastassia ^a   Bakogeorgou, Efstathia ^a   Papakonstanti, Evangelia ^a   Stournaras, Christos ^a   Emmanouel, Dimitrios S ^a   Castanas, Elias ^a,b,c  

^a UNIVERSITY OF CRETE   (Greece)

^b INSERM   (France)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

cell proliferation; opioid receptors (delta, mu, kappa); opioids; opossum kidney cells; somatostatin; somatostatin receptors

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE RECEPTOR; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL DIVISION; CELLS, CULTURED; DIPRENORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; IONS; KIDNEY; MORPHINE; NARCOTICS; OPOSSUMS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECEPTORS, SOMATOSTATIN; SODIUM; SOMATOSTATIN;

EID: 0030447695     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19961215)63:4<410::AID-JCB3>3.0.CO;2-W     Document Type: Article

References (47)

1. Arilla E, Roca B, Prieto JC (1986): Interaction of somatostatin with isolated cytosol from rabbit renal papilla. Peptides 7:741-744.
2. Ashton N, Balment RJ, Blackburn TP (1989): Kappa-opioid-induced changes in renal water and electrolyte management and endocrine secretion. Br J Pharmacol 97:769-776.
3. Berthold H, del-Poso E (1989): Antidiuretic effect of sandostatin (SMS 201-995) in healthy volunteers. Acta Endocrinol (Copenh) 120:708-714.
4. Bhargava HN, Matwyshyn GA, Hanissian S, Tejwani GA (1988): Opioid peptides in pituitary gland and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Brain Res 440:333-340.
5. Brautbar N, Levine BS, Coburn JW, Kleeman CR (1979): Interaction of somatostatin with PTH and AVP: Renal effects. Am J Physiol 237:E428-E431.
6. Bruno JF, Xu Y, Song J, Berelowitz M (1993): Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567.
7. Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C (1985): Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J Neurochem 45:688-699.
8. Chevendra V, Weaver LC (1992): Distributions of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine. Neuroscience 50:727-743.
9. Dave JR, Rubinstein N, Eskay LR (1985): Evidence that β-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclase-adenosine 3′-5′-monophosphate system. Endocrinology 117:1389-1396.
10. Di Bona GF, Jones SY (1994): Role of peripheral opioid mechanisms in renal function. J Am Soc Nephrol 4:1792-1797.
11. Dissanayake VU, Huhues J, Hunter JC (1991): Opioid sites in the guinea pig and rat kidney: Radioligand homogenate binding and autoradiography. Mol Pharmacol 40:93-100.
12. Grzeszczak W, Zukowska-Szczechowska E, Kokot F (1994): Effect of opioid receptor blockade on secretion of atrial natriuretic peptide (ANP) in patients with kidney transplantation. Pol Arch Med Wewn 91:177-183.
13. Hatzoglou A, Ouafik L'H, Bakogeorgou E, Thermos K, Castanas E (1995): Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line, and decreases cell proliferation. Cancer Res 55:5632-5636.
14. Hatzoglou A, Bakogeorgou E, Castanas E (1996): The antiproliferative effect of opioid agonists on the T47D human breast cancer cell line is partially mediated through opioid receptors. Eur J Pharmacol 296:199-207.
15. Hayes AG, Skingle M, Tyers MB (1987): Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-fulnatrexamine. J Pharmacol Exp Ther 240:984-988.
16. Hothi SK, Randall DP, Titheradge MA (1989): [Leu]enkephalin stimulates carbohydrate metabolism in isolated hepatocytes and kidney tubule fragments by interaction with angiotensin II receptors. Biochem J 257:705-710.
17. Kapusta DR, Obih JC (1993): Central kappa opioid receptor-evoked changes in renal function in concious rats: Participation of renal nerves. J Pharmacol Exp Ther 267:197-204.
18. Kapusta DR, Obih JC (1995a): Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism. J Pharmacol Exp Ther 273:199-205.
19. Kapusta DR, Obih JC (1995b): Role of endogenous central opioid mechanisms in maintenance of body sodium balance. Am J Physiol 268:R723-R730.
20. Kapusta DR, Jones SY, Kopp UC, Dibona GF (1989): Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides. J Pharmacol Exp Ther 248: 1039-1047.
21. Keshet E, Polakiewicz RD, Itin A, Ornoy A, Rosen H (1989): Proenkephalin A is expressed in mesodermal lineages during organogenesis. EMBO J 8:2917-2923.
22. Kew D, Kilpatrick DL (1990): Widespread organ expression of the rat proenkephalin gene during early postnatal development. Mol Endocrinol 4:337-340.
23. Lachowicz JE, Shen Y, Monsma FJ Jr, Sibley DR (1995): Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64:34-40.
24. Maneckjee R, Biswas R, Vonderhaar BK (1990): Binding of opioids to human MCF-7 breast cancer cells, and their effects on growth. Cancer Res 50:2234-2238.
25. Mazzocchi G, Malendowicz LK, Meneghelli V, Nussdorfer GG (1992): Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin-angiotensin-aldosterone system. In Vivo 6:9-12.
26. Mosmann T (1973): Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
27. Munson PJ, Rodbard D (1980): LIGAND: A versatile computerized approach to characterization of ligand-binding systems. Anal Biochem 107:220-239.
28. Orbuch M, Taylor JE, Coy DH, Mrozinski JE Jr, Mantey SA, Battey JF, Moreau JP, Jensen RT (1993): Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues. Mol Pharmacol 44:841-850.
29. Papakostanti EA, Emmanouel DS, Gravanis A, Stournaras C (1996): Na+/Pi cotransport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem J 315:241-247.
30. Pittius CW, Kley N, Loeffler JP, Hollt V (1987): Proenkephalin B messenger RNA in porcine tissues: Characterization, quantification, and correlation with opioid peptides. J Neurochem 48:586-592.
31. Quirion R, Finkel MS, Mendelsohn FAO, Zamir N (1983): Localisation of opiate binding sites in the rat kidney and adrenal gland of the rat. Life Sci 33:299-302.
32. Reid IA, Rose JC (1977): An intrarenal effect of somatostatin on water excretion. Endocrinology 100:782-785.
33. Reinecke M, Forssmann WG (1988): Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin-gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry 89:1-9.
34. Reisine T, Bell GI (1993): Molecular biology of opioid receptors. Trends Neurosci 16:506-510.
35. Reisine T, Bell GI (1995): Molecular biology of somatostatin receptors. Endocr Rev 16:427-442.
36. Reisine T, Brownstein M (1995): Opioid and canabinoid receptors. Curr Opin Neurobiol 1:406-412.
37. Reubi JC, Kvols L (1992): Somatostatin receptors in human renal carcinomas. Cancer Res 52:6074-6078.
38. Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA (1993): Human kidney as target for somatostatin: High affinity receptors in tubules and vasa recta. J Clin Endocrinol Metab 77:1323-1328.
39. Reubi JC, Horisberger U, Laissue J (1994): High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? Int J Cancer 56:681-688.
40. Ribstein J, Humphreys MH (1983): Endogenous opioids and electrolyte excretion after contralateral renal exclusion. Am J Physiol 244:F392-F398.
41. Salas SP, Roblero J, Ureta H, Huidobro-Toro JP (1989): Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action. J Pharmacol Exp Ther 250:992-999.
42. Sales N, Dutriez I, Maziere B, Ottaviani M, Roques BP (1991): Neutral endopeptidase 24.11 in rat peripheral tissues: Comparative localization by "ex vivo" and "in vitro" autoradiography. Regul Pept 33:209-222.
43. Sato H, Takeda K, Terasaki T, Tsuji A (1990): Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro. Chem Pharm Bull (Tokyo) 38:3395-3399.
44. 3H-EKC binding by opioids in rat kidney: A correlate to diuretic activity. Life Sci 36:2189-2193.
45. Tulassay T, Tulassay Z, Rascher W, Szücs L, Seyberth HW, Nagy I (1991): Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects. Klin Wochenschr 69:486-490.
46. Vora JP, Owens DR, Ryder R, Ateia J, Luio S, Hayes TM (1986): Effect of somatostatin on renal function. Br Med J 292:1701-1702.
47. Yamada K, Imai M, Yoshida S (1989): Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist. Eur J Pharmacol 160:229-237.